Human studies demonstrate that patients receiving TNF-α inhibitors for chronic inflammatory diseases such as rheumatoid arthritis and Crohnrs disease can develop active TB due to reactivation of latent M. tb infection [12, 22, 28–30], further highlighting the significance of TNF-α in protection against M. tb infection. The gene discussed is TNF; the disease is tuberculosis.